Alimera Sciences Inc reports results for the quarter ended in December - Earnings Summary

Alimera Sciences

07/03/2024 16:03

* Alimera Sciences Inc  ALIM.OQ  reported a quarterly
adjusted
loss of 7 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -54 cents.  The mean expectation of
three analysts for the quarter was for breakeven results per
share. Wall Street expected results to range from -2 cents to 2
cents per share.
    * Revenue rose 87.5% to $26.31 million from a year ago;
analysts
expected $24.34 million. 
    * Alimera Sciences Inc's reported EPS for the quarter was a
loss
of 7 cents​.
    * The company reported a quarterly loss of $3.78 million.
    * Alimera Sciences Inc shares had fallen by 10.4% this
quarter.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Alimera Sciences
Inc is $8.00 
This summary was machine generated from LSEG data March 7 at
04:03 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.00           -0.07          Missed
 Sep. 30 2023      -0.06          -0.06          Met
 Jun. 30 2023      0.02           -1.32          Missed
 Mar. 31 2023      -0.32          -0.71          Missed